Bank of America
CRDF icon

Bank of America’s Cardiff Oncology CRDF Stock Holding History

Bank of America’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.8K Buy
51,119
+9,855
+24% +$20.2K ﹤0.01% 5552
2025
Q4 		$116K Sell
41,264
-8,057
-16% -$18.7K ﹤0.01% 5564
2025
Q3 		$102K Sell
49,321
-44,072
-47% -$122K ﹤0.01% 6585
2025
Q2 		$294K Buy
93,393
+61,110
+189% +$186K ﹤0.01% 5998
2025
Q1 		$101K Sell
32,283
-1,729
-5% -$6.84K ﹤0.01% 6485
2024
Q4 		$148K Sell
34,012
-11,352
-25% -$35.5K ﹤0.01% 6244
2024
Q3 		$121K Sell
45,364
-8,524
-16% -$20.1K ﹤0.01% 6248
2024
Q2 		$120K Sell
53,888
-10,837
-17% -$40.8K ﹤0.01% 6170
2024
Q1 		$346K Buy
64,725
+14,937
+30% +$39.7K ﹤0.01% 5570
2023
Q4 		$73.7K Hold
49,788
– – ﹤0.01% 6489
2023
Q3 		$69.2K Hold
49,788
– – ﹤0.01% 6394
2023
Q2 		$73.2K Sell
49,788
-30,130
-38% -$48.6K ﹤0.01% 6329
2023
Q1 		$132K Buy
79,918
+47,297
+145% +$81.2K ﹤0.01% 6137
2022
Q4 		$45.7K Sell
32,621
-42,248
-56% -$60.5K ﹤0.01% 6501
2022
Q3 		$115K Sell
74,869
-24,966
-25% -$60.1K ﹤0.01% 6276
2022
Q2 		$220K Buy
99,835
+83,370
+506% +$140K ﹤0.01% 6020
2022
Q1 		$41K Sell
16,465
-27,504
-63% -$97.3K ﹤0.01% 7252
2021
Q4 		$264K Sell
43,969
-1,304
-3% -$7.77K ﹤0.01% 6328
2021
Q3 		$301K Buy
45,273
+15,082
+50% +$94.7K ﹤0.01% 6005
2021
Q2 		$200K Sell
30,191
-570,017
-95% -$4.83M ﹤0.01% 6098
2021
Q1 		$5.56M Buy
600,208
+598,922
+46,572% +$7.28M ﹤0.01% 3298
2020
Q4 		$23K Sell
1,286
-49,063
-97% -$862K ﹤0.01% 6558
2020
Q3 		$714K Buy
50,349
+50,279
+71,827% +$332K ﹤0.01% 4455
2020
Q2 		$0 Hold
70
– – ﹤0.01% 6862
2020
Q1 		$0 Hold
70
– – ﹤0.01% 6900
2019
Q4 		$0 Sell
70
-262
-79% -$373 ﹤0.01% 7121
2019
Q3 		$0 Buy
332
+262
+374% +$510 ﹤0.01% 7279
2019
Q2 		$0 Hold
70
– – ﹤0.01% 7210
2019
Q1 		$0 Hold
70
– – ﹤0.01% 7145
2018
Q4 		$0 Sell
70
-828
-92% -$3.77K ﹤0.01% 7145
2018
Q3 		$4K Buy
898
+817
+1,009% +$3.87K ﹤0.01% 6867
2018
Q2 		$0 Hold
81
– – ﹤0.01% 7107
2018
Q1 		$2K Hold
81
– – ﹤0.01% 6887
2017
Q4 		$2K Sell
81
-14
-15% -$620 ﹤0.01% 6853
2017
Q3 		$5K Hold
95
– – ﹤0.01% 6720
2017
Q2 		$9K Sell
95
-1
-1% -$64 ﹤0.01% 6450
2017
Q1 		$8K Buy
96
+28
+41% +$3.8K ﹤0.01% 6589
2016
Q4 		$10K Buy
68
+36
+113% +$8.41K ﹤0.01% 6550
2016
Q3 		$10K Buy
32
+15
+88% +$5.47K ﹤0.01% 6380
2016
Q2 		$5K Buy
+17
New +$5.86K ﹤0.01% 6671
2016
Q1 		– Sell
-62
Closed -$24K – 7049
2015
Q4 		$24K Sell
62
-21
-25% -$8.22K ﹤0.01% 6354
2015
Q3 		$34K Buy
83
+33
+66% +$17.3K ﹤0.01% 6115
2015
Q2 		$36K Buy
+50
New +$35.5K ﹤0.01% 6092
2014
Q3 		– Sell
-283
Closed -$71K – 8018
2014
Q2 		$71K Buy
+283
New +$90.6K ﹤0.01% 6381
2014
Q1 		– Sell
-1
Closed – – 7822
2013
Q4 		$0 Sell
1
-4
-80% -$1.78K ﹤0.01% 7914
2013
Q3 		$2K Hold
5
– – ﹤0.01% 7618
2013
Q2 		$2K Buy
+5
New +$2.26K ﹤0.01% 7506

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Bank of America's CRDF Position: Q1 2026 in Review

Bank of America increased its Cardiff Oncology (CRDF) stake by 24% in Q1 2026, buying an estimated $20.2K and bringing the position to 51,119 shares worth $82.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5552.

Bank of America first reported a position in CRDF in Q2 2013 and has held it in 47 quarters since. The position peaked at $5.56M in Q1 2021. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Bank of America held 51,119 shares of Cardiff Oncology worth $82.8K as of Q1 2026.
  • Bank of America bought 9,855 Cardiff Oncology shares in Q1 2026, an estimated $20.2K.
  • Cardiff Oncology made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5552 holding.
  • Bank of America first reported a position in Cardiff Oncology in Q2 2013 and has held it in 47 quarters since.
  • Bank of America's Cardiff Oncology position peaked at $5.56M in Q1 2021.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.